Medicare Enrolled
Dr. Eric Harris, D.O.
Hematology · Daytona Beach, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Harris from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Harris?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Harris
Dr. Eric Harris is a hematology specialist in Daytona Beach, FL, with 17 years of NPI registration. Based on federal Medicare data, Dr. Harris performed 87,698 Medicare services across 2,247 unique beneficiaries.
Between the years covered by Open Payments, Dr. Harris received a total of $150,121 from 85 pharmaceutical and/or device companies across 879 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Harris is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 49% volume in FL
$150,121 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Osteopathic Physician | 12441 | Clear | March 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗87,698
Medicare services
Top 49% in FL for hematology
2,247
Unique beneficiaries
$17
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~5,159 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 27,400 | $43 | $137 |
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
20,250 | $1 | $3 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
14,790 | $0 | $4 |
| Anti-nausea injection (aprepitant) | 10,400 | $1 | $5 |
| Denosumab injection (Prolia/Xgeva) | 3,900 | $19 | $51 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,044 | $0 | $3 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,322 | $8 | $29 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,102 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,030 | $1 | $28 |
| Anti-nausea injection (ondansetron/Zofran) | 800 | $0 | $9 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
614 | $64 | $239 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
547 | $12 | $61 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
524 | $96 | $378 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
451 | $2 | $41 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
434 | $95 | $339 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
359 | $10 | $69 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
170 | $1 | $3 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
137 | $48 | $178 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
116 | $47 | $189 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
116 | $7 | $69 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
114 | $22 | $84 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
104 | $1 | $6 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
102 | $62 | $197 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
97 | $3 | $11 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
84 | $136 | $556 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
75 | $28 | $156 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
70 | $22 | $79 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
65 | $2 | $8 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
59 | $24 | $89 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 57 | $134 | $562 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
45 | $10 | $42 |
| New patient office visit, complex (60-74 min) | 43 | $167 | $585 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
41 | $42 | $170 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
40 | $16 | $59 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
38 | $25 | $156 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
37 | $15 | $56 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
37 | $2 | $7 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
20 | $94 | $285 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
19 | $1 | $7 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
17 | $115 | $453 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
16 | $41 | $147 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
12 | $140 | $474 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
41.1% high complexity
54.3% medium
4.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$150,121
Total received (2018-2024)
Avg $21,446/year across 7 years
Top 3% in FL for hematology
85
Companies
879
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$126,110 (84.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$12,432 (8.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,364 (6.9%)
Other
Charitable contributions, space rental, and other categories
$1,215 (0.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,664
2023
$2,886
2022
$8,656
2021
$22,820
2020
$13,712
2019
$42,932
2018
$56,451
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$71,799
E.R. Squibb & Sons, L.L.C.
$41,726
Gilead Sciences, Inc.
$13,619
AstraZeneca Pharmaceuticals LP
$8,488
Immunomedics, Inc.
$2,500
Celgene Corporation
$1,333
Rigel Pharmaceuticals, Inc.
$1,025
Seattle Genetics, Inc.
$949
PFIZER INC.
$650
Janssen Biotech, Inc.
$551
Genentech USA, Inc.
$514
Merck Sharp & Dohme LLC
$439
Amgen Inc.
$397
Merck Sharp & Dohme Corporation
$377
Lilly USA, LLC
$301
Incyte Corporation
$287
GENZYME CORPORATION
$255
Kite Pharma, Inc.
$235
Eisai Inc.
$229
Seagen Inc.
$215
Daiichi Sankyo Inc.
$210
Ipsen Biopharmaceuticals, Inc
$186
Astellas Pharma US Inc
$180
Exelixis Inc.
$177
NOVARTIS PHARMACEUTICALS CORPORATION
$167
ABBVIE INC.
$152
Bayer Healthcare Pharmaceuticals Inc.
$150
BeiGene USA, Inc.
$143
Bayer HealthCare Pharmaceuticals Inc.
$143
Foundation Medicine, Inc.
$142
Boehringer Ingelheim Pharmaceuticals, Inc.
$137
EMD Serono, Inc.
$134
TESARO, Inc.
$132
Pharmacosmos Therapeutics Inc.
$102
Puma Biotechnology, Inc.
$101
Takeda Pharmaceuticals U.S.A., Inc.
$99
SANOFI-AVENTIS U.S. LLC
$95
TAIHO ONCOLOGY, INC.
$92
JAZZ PHARMACEUTICALS INC.
$90
GlaxoSmithKline, LLC.
$90
Mirati Therapeutics, Inc.
$82
Regeneron Healthcare Solutions, Inc.
$74
ARRAY BIOPHARMA INC
$68
Janssen Pharmaceuticals, Inc
$62
TerSera Therapeutics LLC
$59
Lexicon Pharmaceuticals, Inc.
$58
EISAI INC.
$57
Heron Therapeutics, Inc.
$57
PharmaEssentia USA Corporation
$57
G1 Therapeutics, Inc.
$52
Clovis Oncology, Inc.
$51
AbbVie, Inc.
$48
Alexion Pharmaceuticals, Inc.
$47
AMAG Pharmaceuticals, Inc.
$41
CSL Behring
$39
MEDIVATION FIELD SOLUTIONS LLC
$39
SOBI, INC
$37
Myriad Genetic Laboratories, Inc.
$33
Secura Bio, Inc.
$32
CTI BioPharma Corp.
$30
Stemline Therapeutics Inc.
$29
RECORDATI_RARE_DISEASES_INC.
$29
Alnylam Pharmaceuticals Inc.
$27
Aurobindo Pharma USA, Inc.
$27
Taiho Oncology, Inc.
$26
Aveo Pharmaceuticals, Inc.
$26
Horizon Therapeutics plc
$26
Agios Pharmaceuticals, Inc.
$26
Blueprint Medicines Corporation
$25
Sun Pharmaceutical Industries Inc.
$24
Adaptive Biotechnologies Corporation
$22
Emmaus Medical, Inc.
$18
Global Blood Therapeutics, Inc.
$18
MorphoSys, US Inc.
$18
EUSA Pharma (US) LLC
$17
Coherus Biosciences Inc.
$17
PUMA BIOTECHNOLOGY, INC.
$16
Abbott Laboratories
$16
Pharmacyclics LLC, An AbbVie Company
$16
Jazz Pharmaceuticals Inc.
$15
Dendreon Pharmaceuticals LLC
$14
Array BioPharma Inc.
$13
SECURA BIO, INC.
$11
Teva Pharmaceuticals USA, Inc.
$11
Veracyte, Inc.
$3
Top 3 companies account for 84.7% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · AYVAKIT · Abraxane · Afstyla · Alecensa · Avastin · BAVENCIO · BENDEKA · BESREMI · BOSULIF · BRACANALYSIS CDX · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CINVANTI · COPIKTRA · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELITEK · EMPLICITI · ENHERTU · ERBITUX · ERLEADA · Endari · Enhertu · Erleada · FARYDAK · FASENRA · FERAHEME · FOTIVDA · FOUNDATIONONE · FREESTYLE LIBRE 3 · FRUZAQLA · Fabhalta · Farydak · Folotyn · GAZYVA · GILOTRIF · GIVLAARI · Gazyva · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Idelvion · Imbruvica · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · KRYSTEXXA · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MVASI · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OJJAARA · OPDIVO · OPDUALAG · OXBRYTA · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · Padcev · Perjeta · Polivy · Pomalyst · REBLOZYL · RYBREVANT · RYDAPT · Revlimid · Rituxan Hycela · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SOLIRIS · SOMATULINE DEPOT · SUSTOL · SUTENT · SYLVANT · Somatuline Depot · Stivarga · Sylvant · TAFINLAR · TAGRISSO · TASIGNA · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VOTRIENT · VYXEOS · Vanflyta · Venclexta · Vitrakvi · Vonjo · Vyloy · XALKORI · XARELTO · XOSPATA · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA (abiraterone acetate) · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (84%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for hematology in FL.
Equivalent to $171 per 100 Medicare services performed
Geographic Context
Hematologists within 10 mi
9
Per 100K population
1.6
County median income
$66,581
Nearest hospital
ADVENTHEALTH DAYTONA BEACH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Harris is a mixed practice specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 3% of FL peers, with 17 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Harris experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Dr. Harris performed 27,400 pembrolizumab injection (keytruda) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Harris receive payments from pharmaceutical companies?
Yes. Dr. Harris received a total of $150,121 from 85 companies across 879 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Harris's costs compare to other hematologists in Daytona Beach?
Dr. Harris's average Medicare payment per service is $17. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Harris) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Daytona Beach
Browse hematologists in Daytona Beach ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in FL
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in FL
Which FL hematologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology